Published in Ann Surg Oncol on April 27, 2010
Advanced-stage pancreatic cancer: therapy options. Nat Rev Clin Oncol (2013) 1.34
Novel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: time to modify the current American Joint Committee on Cancer staging system. J Clin Oncol (2011) 1.02
Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma: a stage-matched comparison of outcomes. Cancer (2010) 1.00
Therapeutic options for the management of pancreatic cancer. World J Gastroenterol (2014) 0.96
Minimally invasive RAMPS in well-selected left-sided pancreatic cancer within Yonsei criteria: long-term (>median 3 years) oncologic outcomes. Surg Endosc (2014) 0.94
A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma. Genome Med (2014) 0.92
The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma. Oncotarget (2016) 0.91
Factors associated with local-regional recurrence after a negative sentinel node dissection: results of the ACOSOG Z0010 trial. Ann Surg (2012) 0.90
Molecular pathology of pancreatic cancer: from bench-to-bedside translation. Curr Drug Targets (2012) 0.86
Conditional survival in pancreatic cancer: better than expected. HPB (Oxford) (2011) 0.84
When to puncture, when not to puncture: Pancreatic masses. Endosc Ultrasound (2014) 0.83
Long-term survival in patients with pancreatic ductal adenocarcinoma. Surgery (2016) 0.81
A mutated anti-CA19-9 scFv-Fc for positron emission tomography of human pancreatic cancer xenografts. Mol Imaging Biol (2014) 0.80
Generation and characterisation of novel pancreatic adenocarcinoma xenograft models and corresponding primary cell lines. PLoS One (2014) 0.80
A subgroup of pancreatic adenocarcinoma is sensitive to the 5-aza-dC DNA methyltransferase inhibitor. Oncotarget (2015) 0.78
Peripancreatic soft tissue involvement: independent outcome predictor in patients with resected pancreatic adenocarcinoma. Int Surg (2014) 0.77
Impact of Intratumoral Inflammation on Survival After Pancreatic Cancer Resection. Pancreas (2016) 0.77
CT-perfusion measurements in pancreatic carcinoma with different kinetic models: Is there a chance for tumour grading based on functional parameters? Cancer Imaging (2016) 0.75
Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas. World J Gastroenterol (2016) 0.75
What is the major prognostic factor in tumor-node-metastasis staging of pancreatic adenocarcinoma? Ann Surg Oncol (2010) 0.75
Reg proteins promote acinar-to-ductal metaplasia and act as novel diagnostic and prognostic markers in pancreatic ductal adenocarcinoma. Oncotarget (2016) 0.75
Equipping the American Joint Committee on Cancer staging for resectable pancreatic ductal adenocarcinoma with tumor grade: a recursive partitioning analysis. Med Oncol (2016) 0.75
Disparities in use of gynecologic oncologists for women with ovarian cancer in the United States. Health Serv Res (2012) 0.75
Predictive risk factors for peritoneal recurrence after pancreatic cancer resection and strategies for its prevention. Surg Today (2017) 0.75
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA (2007) 14.54
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med (2004) 13.34
1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. J Gastrointest Surg (2006) 7.18
Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg (1993) 6.15
Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg (1995) 4.17
Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg (2007) 4.09
Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg (2003) 3.13
Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database. Cancer (2007) 2.85
Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg (2004) 2.84
Outcomes in octogenarians undergoing high-risk cancer operation: a national study. J Am Coll Surg (2007) 2.23
Survival after resection for ductal adenocarcinoma of the pancreas. Br J Surg (1996) 2.07
Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients. Eur J Cancer (2004) 2.00
Factors influencing survival after resection for ductal adenocarcinoma of the head of the pancreas. J Surg Oncol (2000) 1.89
Extent of lymph node retrieval and pancreatic cancer survival: information from a large US population database. Ann Surg Oncol (2006) 1.84
The staging of cancer: a retrospective and prospective appraisal. CA Cancer J Clin (2008) 1.51
Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survival. J Clin Oncol (2005) 1.37
Accuracy of staging node-negative pancreas cancer: a potential quality measure. Arch Surg (2007) 1.25
Clinicopathologic evaluation after resection for ductal adenocarcinoma of the pancreas: a retrospective, single-institution experience. Pancreas (2003) 1.19
Pancreatic resection in the elderly. J Am Coll Surg (2004) 1.11
Prognostic factors in the operative treatment of ductal pancreatic carcinoma. Langenbecks Arch Surg (2000) 1.06
A proposal for a new and more practical grading scheme for pancreatic ductal adenocarcinoma. Am J Surg Pathol (2005) 0.99
Strength of the evidence: adjuvant therapy for resected pancreatic cancer. J Gastrointest Surg (2007) 0.95
Prognostic factors of long-term survival after resective procedures for pancreatic cancer. Hepatogastroenterology (2002) 0.92
Cytologic grade independently predicts survival of patients with pancreatic adenocarcinoma. Am J Clin Pathol (2005) 0.84
Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst (2004) 10.61
Extent of surgery affects survival for papillary thyroid cancer. Ann Surg (2007) 4.73
The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol (2008) 3.82
National failure to operate on early stage pancreatic cancer. Ann Surg (2007) 3.65
Toward robust information: data quality and inter-rater reliability in the American College of Surgeons National Surgical Quality Improvement Program. J Am Coll Surg (2009) 3.55
Disparities in the utilization of high-volume hospitals for complex surgery. JAMA (2006) 3.35
Updated population-based review of carcinoid tumors. Ann Surg (2004) 3.21
Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg (2009) 3.07
Does surgical quality improve in the American College of Surgeons National Surgical Quality Improvement Program: an evaluation of all participating hospitals. Ann Surg (2009) 3.05
Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database. Cancer (2007) 2.85
Directing surgical quality improvement initiatives: comparison of perioperative mortality and long-term survival for cancer surgery. J Clin Oncol (2008) 2.74
A comparison of clinical registry versus administrative claims data for reporting of 30-day surgical complications. Ann Surg (2012) 2.72
The aging population and its impact on the surgery workforce. Ann Surg (2003) 2.70
Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology (2012) 2.69
American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures. J Clin Oncol (2008) 2.69
Effect of delay to operation on outcomes in adults with acute appendicitis. Arch Surg (2010) 2.53
Blueprint for a new American College of Surgeons: National Surgical Quality Improvement Program. J Am Coll Surg (2008) 2.53
Lymph node evaluation as a colon cancer quality measure: a national hospital report card. J Natl Cancer Inst (2008) 2.46
A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum. Dis Colon Rectum (2005) 2.45
Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons. J Am Coll Surg (2013) 2.37
Autoimmune pancreatitis: imaging features. Radiology (2004) 2.34
Evaluation of surveillance bias and the validity of the venous thromboembolism quality measure. JAMA (2013) 2.31
Rates of colon and rectal cancers are increasing in young adults. Am Surg (2003) 2.30
Readmissions following pancreaticoduodenectomy for pancreas cancer: a population-based appraisal. Ann Surg Oncol (2008) 2.20
Do young colon cancer patients have worse outcomes? World J Surg (2004) 2.20
Validity and feasibility of the american college of surgeons colectomy composite outcome quality measure. Ann Surg (2013) 2.18
Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts. Gut (2012) 2.17
Factors predicting complication rates following total knee replacement. J Bone Joint Surg Am (2006) 2.15
Quality improvement in surgery: the American College of Surgeons National Surgical Quality Improvement Program approach. Adv Surg (2010) 2.14
Risk adjustment for comparing hospital quality with surgery: how many variables are needed? J Am Coll Surg (2010) 2.12
The influence of resident involvement on surgical outcomes. J Am Coll Surg (2011) 2.12
Hospitalization before and after gastric bypass surgery. JAMA (2005) 2.12
Use and outcomes of laparoscopic-assisted colectomy for cancer in the United States. Arch Surg (2008) 2.10
Malignancies of the appendix: beyond case series reports. Dis Colon Rectum (2005) 2.02
Surgery for hepatocellular carcinoma: does it improve survival? Ann Surg Oncol (2004) 2.01
Mutant TP53 in duodenal samples of pancreatic juice from patients with pancreatic cancer or high-grade dysplasia. Clin Gastroenterol Hepatol (2012) 1.99
Optimal preoperative assessment of the geriatric surgical patient: a best practices guideline from the American College of Surgeons National Surgical Quality Improvement Program and the American Geriatrics Society. J Am Coll Surg (2012) 1.94
Assessment of pancreatic cancer care in the United States based on formally developed quality indicators. J Natl Cancer Inst (2009) 1.92
Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. J Clin Oncol (2009) 1.90
Reliability of superficial surgical site infections as a hospital quality measure. J Am Coll Surg (2011) 1.90
Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients. Ann Surg (2008) 1.90
Association between occurrence of a postoperative complication and readmission: implications for quality improvement and cost savings. Ann Surg (2013) 1.87
Preoperative predictors of weight loss following bariatric surgery: systematic review. Obes Surg (2012) 1.86
Thirty-day mortality statistics underestimate the risk of repair of thoracoabdominal aortic aneurysms: a statewide experience. J Vasc Surg (2006) 1.84
Optimizing ACS NSQIP modeling for evaluation of surgical quality and risk: patient risk adjustment, procedure mix adjustment, shrinkage adjustment, and surgical focus. J Am Coll Surg (2013) 1.84
Identification of specific quality improvement opportunities for the elderly undergoing gastrointestinal surgery. Arch Surg (2009) 1.83
Development of an American College of Surgeons National Surgery Quality Improvement Program: morbidity and mortality risk calculator for colorectal surgery. J Am Coll Surg (2009) 1.83
Evaluation of the guidelines for management of pancreatic branch-duct intraductal papillary mucinous neoplasm. Clin Gastroenterol Hepatol (2008) 1.82
Cancer-directed surgery for localized disease: decreased use in the elderly. Ann Surg Oncol (2004) 1.80
Comparison of outcomes after laparoscopic versus open appendectomy for acute appendicitis at 222 ACS NSQIP hospitals. Surgery (2010) 1.77
Underuse of axillary dissection for the management of sentinel node micrometastases in breast cancer. Arch Surg (2010) 1.76
Comparison of commission on cancer-approved and -nonapproved hospitals in the United States: implications for studies that use the National Cancer Data Base. J Clin Oncol (2009) 1.75
Comparison of 30-day outcomes after emergency general surgery procedures: potential for targeted improvement. Surgery (2010) 1.74
Measuring the quality of colorectal cancer screening: the importance of follow-up. Dis Colon Rectum (2006) 1.72
Colonic stent vs. emergency surgery for management of acute left-sided malignant colonic obstruction: a decision analysis. Gastrointest Endosc (2004) 1.70
Variability in length of stay after colorectal surgery: assessment of 182 hospitals in the national surgical quality improvement program. Ann Surg (2009) 1.70
Reliability adjustment for reporting hospital outcomes with surgery. Ann Surg (2012) 1.70
Are survival rates different for young and older patients with rectal cancer? Dis Colon Rectum (2004) 1.69
Small bowel obstruction: a population-based appraisal. J Am Coll Surg (2006) 1.65
Surgeon volume as a predictor of outcomes in inpatient and outpatient endocrine surgery. Surgery (2007) 1.65
Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume. Cancer (2007) 1.63
Missing data in the American College of Surgeons National Surgical Quality Improvement Program are not missing at random: implications and potential impact on quality assessments. J Am Coll Surg (2010) 1.62
A meta-analysis of perioperative beta blockade: what is the actual risk reduction? Surgery (2005) 1.61
Pancreatectomy risk calculator: an ACS-NSQIP resource. HPB (Oxford) (2010) 1.61
Complete lymph node dissection for sentinel node-positive melanoma: assessment of practice patterns in the United States. Ann Surg Oncol (2008) 1.60
Wait times for cancer surgery in the United States: trends and predictors of delays. Ann Surg (2011) 1.59
Risk factors for superficial vs deep/organ-space surgical site infections: implications for quality improvement initiatives. JAMA Surg (2013) 1.59
Using the NCDB for cancer care improvement: an introduction to available quality assessment tools. J Surg Oncol (2009) 1.58
Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats. Clin Chem (2006) 1.58
Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: results from RTOG 9704. J Clin Oncol (2010) 1.57
Effect of postoperative complications on adjuvant chemotherapy use for stage III colon cancer. Ann Surg (2013) 1.56
Risk-based selective referral for cancer surgery: a potential strategy to improve perioperative outcomes. Ann Surg (2010) 1.53
Do young breast cancer patients have worse outcomes? J Surg Res (2003) 1.53
Delayed progression of pancreatic intraepithelial neoplasia in a conditional Kras(G12D) mouse model by a selective cyclooxygenase-2 inhibitor. Cancer Res (2007) 1.52
Complication rates following open reduction and internal fixation of ankle fractures. J Bone Joint Surg Am (2009) 1.50
Risk of surgery following recent myocardial infarction. Ann Surg (2011) 1.47
Management of pancreatic fistulas after pancreaticoduodenectomy: results in 437 consecutive patients. Arch Surg (2005) 1.47
Comparison of hospital performance in trauma vs emergency and elective general surgery: implications for acute care surgery quality improvement. Arch Surg (2012) 1.46
Variation in lymph node examination after esophagectomy for cancer in the United States. Arch Surg (2012) 1.46
Effect of hospital volume on margin status after pancreaticoduodenectomy for cancer. J Am Coll Surg (2008) 1.46
Comparison of reoperation rates following ankle arthrodesis and total ankle arthroplasty. J Bone Joint Surg Am (2007) 1.45
A population-based study of colorectal cancer test use: results from the 2001 California Health Interview Survey. Cancer (2004) 1.45
Relevance of the c-statistic when evaluating risk-adjustment models in surgery. J Am Coll Surg (2012) 1.45
Negative appendectomy in pregnant women is associated with a substantial risk of fetal loss. J Am Coll Surg (2007) 1.44
Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors. J Am Coll Surg (2007) 1.44
Are 12 nodes needed to accurately stage T1 and T2 colon cancers? Dig Dis Sci (2008) 1.44
The role of Surgical Champions in the American College of Surgeons National Surgical Quality Improvement Program--a national survey. J Surg Res (2010) 1.43
Pseudomyxoma peritonei is a disease of MUC2-expressing goblet cells. Am J Pathol (2002) 1.42
Clinicopathologic features and treatment trends of pancreatic neuroendocrine tumors: analysis of 9,821 patients. J Gastrointest Surg (2007) 1.41